Literature DB >> 17391904

Utility of 18F-fluorodeoxyglucose positron emission tomography in the preoperative staging of squamous cell carcinoma of the oropharynx.

M R Kim1, J-L Roh, J S Kim, J H Lee, K-J Cho, S-H Choi, S Y Nam, S Y Kim.   

Abstract

BACKGROUND: 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) has been reported to be superior to computed tomography (CT)/magnetic resonance imaging (MRI) in the evaluation of head and neck cancers, but little is known about its usefulness in oropharyngeal squamous cell carcinoma (SCC). We therefore compared FDG PET and CT/MRI in the preoperative staging of previously untreated oropharyngeal SCC.
METHODS: Thirty-two consecutive patients with oropharyngeal SCC underwent FDG PET and CT/MRI before surgery. Each method was interpreted separately to assess primary tumor and cervical node status. Their sensitivity and specificity were compared relative to histopathologic analysis.
RESULTS: Histopathology revealed metastases in 29 of 39 dissected neck sides and in 47 of 163 dissected cervical levels. FDG PET had higher sensitivities than CT/MRI for primary tumor detection (25/32 vs. 30/32, P=0.063) and for identification of cervical metastases on neck side (22/29 vs. 28/29, P<0.05) and level-by-level (37/47 vs. 45/47, P<0.05) bases. In contrast, the specificity of the two methods did not differ significantly (P>0.5). FDG PET correctly interpreted the false-negative results of CT/MRI in 6 of 7 primary tumors and 8 of 10 cervical levels.
CONCLUSIONS: The improved preoperative staging of FDG PET may help in planning treatment, but its accuracy is insufficient to replace pathologic staging based on neck dissection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17391904     DOI: 10.1016/j.ejso.2007.02.016

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  8 in total

Review 1.  Role of fluorine-18 fluorodeoxyglucose PET/CT in head and neck oncology: the point of view of the radiation oncologist.

Authors:  Jon Cacicedo; Arturo Navarro; Olga Del Hoyo; Alfonso Gomez-Iturriaga; Filippo Alongi; Jose A Medina; Olgun Elicin; Andrea Skanjeti; Francesco Giammarile; Pedro Bilbao; Francisco Casquero; Berardino de Bari; Alan Dal Pra
Journal:  Br J Radiol       Date:  2016-08-02       Impact factor: 3.039

2.  18F-Fluorodeoxyglucose-PET/CT in locally advanced head and neck cancer can influence the stage migration and nodal radiation treatment volumes.

Authors:  Rosario Mazzola; Pierpaolo Alongi; Francesco Ricchetti; Alba Fiorentino; Sergio Fersino; Niccolò Giaj-Levra; Matteo Salgarello; Filippo Alongi
Journal:  Radiol Med       Date:  2017-08-28       Impact factor: 3.469

3.  FDG-PET/CT in cancers of the head and neck: what is the definition of whole body scanning?

Authors:  Andrei Iagaru; Erik S Mittra; Sanjiv Sam Gambhir
Journal:  Mol Imaging Biol       Date:  2011-04       Impact factor: 3.488

4.  Should PET/CT be implemented in the routine imaging work-up of locally advanced head and neck squamous cell carcinoma? A prospective analysis.

Authors:  Jon Cacicedo; Iratxe Fernandez; Olga Del Hoyo; Ainara Dolado; Javier Gómez-Suarez; Eduardo Hortelano; Aintzane Sancho; Jose I Pijoan; Julio Alvarez; Jose M Espinosa; Ayman Gaafar; Pedro Bilbao
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-05-08       Impact factor: 9.236

5.  18F-Fluorodeoxyglucose-PET/CT to evaluate tumor, nodal disease, and gross tumor volume of oropharyngeal and oral cavity cancer: comparison with MR imaging and validation with surgical specimen.

Authors:  Oliver Seitz; Nicole Chambron-Pinho; Markus Middendorp; Rober Sader; Martin Mack; Thomas J Vogl; Sotirios Bisdas
Journal:  Neuroradiology       Date:  2009-10       Impact factor: 2.804

6.  Impact of pretreatment second look 18FDG-PET/CT on stage and treatment changes in head and neck cancer.

Authors:  Olgun Elicin; Bernd Vollnberg; Mohamed Shelan; Elena Riggenbach; Beat Bojaxhiu; Etienne Mathier; Roland Giger; Daniel M Aebersold; Bernd Klaeser
Journal:  Clin Transl Radiat Oncol       Date:  2021-08-29

7.  Clinical Applications of FDG PET and PET/CT in Head and Neck Cancer.

Authors:  Akram Al-Ibraheem; Andreas Buck; Bernd Joachim Krause; Klemens Scheidhauer; Markus Schwaiger
Journal:  J Oncol       Date:  2009-08-20       Impact factor: 4.375

8.  Prognostic Value of FDG-PET in patients with oropharyngeal carcinoma treated with concurrent chemoradiotherapy.

Authors:  Keisuke Enomoto; Hidenori Inohara; Ichiro Higuchi; Kenichiro Hamada; Yoichiro Tomiyama; Takeshi Kubo; Jun Hatazawa
Journal:  Mol Imaging Biol       Date:  2008-06-05       Impact factor: 3.488

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.